- Home
- KNF vs AXSM Comparison
KNF vs AXSM Comparison
Compare KNF & AXSM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- KNF
- AXSM
- Stock Information
- Founded
- KNF 1917
- AXSM 2012
- Country
- KNF United States
- AXSM United States
- Employees
- KNF N/A
- AXSM N/A
- Industry
- KNF
- AXSM Biotechnology: Pharmaceutical Preparations
- Sector
- KNF
- AXSM Health Care
- Exchange
- KNF Nasdaq
- AXSM Nasdaq
- Market Cap
- KNF 5.3B
- AXSM 5.1B
- IPO Year
- KNF N/A
- AXSM 2015
- Fundamental
- Price
- KNF $80.00
- AXSM $105.00
- Analyst Decision
- KNF Strong Buy
- AXSM Strong Buy
- Analyst Count
- KNF 6
- AXSM 17
- Target Price
- KNF $117.17
- AXSM $171.65
- AVG Volume (30 Days)
- KNF 816.8K
- AXSM 649.3K
- Earning Date
- KNF 08-05-2025
- AXSM 08-04-2025
- Dividend Yield
- KNF N/A
- AXSM N/A
- EPS Growth
- KNF 1.95
- AXSM N/A
- EPS
- KNF 3.18
- AXSM N/A
- Revenue
- KNF $2,922,886,000.00
- AXSM $432,157,000.00
- Revenue This Year
- KNF $15.00
- AXSM $62.84
- Revenue Next Year
- KNF $7.17
- AXSM $60.02
- P/E Ratio
- KNF $25.34
- AXSM N/A
- Revenue Growth
- KNF 2.48
- AXSM 72.16
- 52 Week Low
- KNF $67.22
- AXSM $72.21
- 52 Week High
- KNF $108.83
- AXSM $139.13
- Technical
- Relative Strength Index (RSI)
- KNF 41.72
- AXSM 47.99
- Support Level
- KNF $79.21
- AXSM $102.26
- Resistance Level
- KNF $85.04
- AXSM $106.35
- Average True Range (ATR)
- KNF 3.23
- AXSM 3.09
- MACD
- KNF 0.29
- AXSM 0.15
- Stochastic Oscillator
- KNF 55.56
- AXSM 66.44
About KNF Knife Riv Holding Co.
Knife River Holding Co is an aggregates-led construction materials and contracting services provider. Its segments include Pacific, Northwest, Mountain, North Central, South, and Energy Services. Each geographic segment offers a vertically integrated suite of products and services, including aggregates, ready-mix concrete, asphalt, and contracting services, while the Energy Services segment, which has locations throughout the company's geographic footprint, produces and supplies liquid asphalt and related services, for use in asphalt road construction, and is a supplier to some of the other segments.
About AXSM Axsome Therapeutics Inc.
Axsome Therapeutics Inc is a clinical-stage biopharmaceutical company. It is engaged in developing novel therapies for the management of the central nervous system, or CNS, disorders for which there are limited treatment options. Its pipeline products includes AXS-05, AXS-07, AXS-12, and AXS-14. It manages its business as one operating segment and reporting unit, which is the business of developing and delivering novel therapies for the management of CNS disorders.